| Application no. and date | 15164931.6 (espacenet) (Federated) (European Patent Register), 20110124 | | Patent/reg. no. and date | DK/EP 2932970, 20180321 | | Publication date | 20151021 | | Priority no. and date | US 298589 P, 20100127 | | EP pub. no. and date |
EP 2932970 20151021 | | Effective date | | | Applicant/owner | VIIV Healthcare Company, 251 Little Falls Drive
Wilmington, DE 19808, US | | Applicant ref. no. | 161485 | | Inventor | Underwood, Mark Richard, c/o GlaxoSmithKline, Global Patents Dept
Five Moore Drive
Research Triangle Park, NC North Carolina 27709, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/505 (2006.01) , A61K 31/5365 (2006.01) , A61P 31/18 (2006.01) | | Title | ANTIVIRAL TERAPI | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | CA 2018 00036 | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
